Remarkably, p53-depedent changes in chromatin accessibility not only correlate with changes in gene expression but also with high frequencies of genomic rearrangements of these genes in pancreatic cancer patients [46] (Fig. 3). The gene discussed is TP53; the disease is pancreatic neoplasm.